BioClinica

Activities: Regulatory

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Regulatory

Bioclinica acquires Clinverse

Expanding into financial management solutions for clinical trials
Regulatory

BioClinica acquires Synowledge

Adds capabilities in pharmacovigilance and regulatory technology, data analysis and business process management
Regulatory

BioClinica expands eClinical leadership team

Andrew Masters and Angelo Stortini take key roles in the eClinical solutions team
Regulatory

BioClinica software offers better sponsor control over trial timelines

Programme has potential to change the way sponsors and CROs use technology to run clinical trials
Regulatory

GSK to use BioClinica Interactive Web Response solution

The pharma giant has signed a multi-year agreement for global trial management technology
Subscribe now